News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,825 Results
Type
Article (41752)
Company Profile (252)
Press Release (666820)
Multimedia
Podcasts (63)
Webinars (14)
Section
Business (204788)
Career Advice (2053)
Deals (35527)
Drug Delivery (95)
Drug Development (81416)
Employer Resources (173)
FDA (16349)
Job Trends (14934)
News (346532)
Policy (32782)
Tag
Academia (2601)
Accelerated approval (10)
Adcomms (22)
Allergies (95)
Alliances (49714)
ALS (112)
Alzheimer's disease (1452)
Antibody-drug conjugate (ADC) (153)
Approvals (16343)
Artificial intelligence (314)
Autoimmune disease (29)
Automation (19)
Bankruptcy (361)
Best Places to Work (11665)
BIOSECURE Act (20)
Biosimilars (124)
Biotechnology (176)
Bladder cancer (94)
Brain cancer (35)
Breast cancer (367)
Cancer (2889)
Cardiovascular disease (216)
Career advice (1718)
Career pathing (30)
CAR-T (186)
CDC (32)
Cell therapy (502)
Cervical cancer (22)
Clinical research (67044)
Collaboration (1022)
Company closure (3)
Compensation (690)
Complete response letters (24)
COVID-19 (2640)
CRISPR (58)
C-suite (331)
Cystic fibrosis (113)
Data (3019)
Decentralized trials (2)
Denatured (21)
Depression (61)
Diabetes (346)
Diagnostics (6441)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (140)
Drug pricing (123)
Drug shortages (28)
Duchenne muscular dystrophy (130)
Earnings (87578)
Editorial (41)
Employer branding (21)
Employer resources (149)
Events (114125)
Executive appointments (846)
FDA (18011)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (935)
Gene editing (133)
Generative AI (23)
Gene therapy (379)
GLP-1 (787)
Government (4535)
Grass and pollen (4)
Guidances (181)
Healthcare (18909)
HIV (40)
Huntington's disease (31)
IgA nephropathy (40)
Immunology and inflammation (147)
Immuno-oncology (10)
Indications (39)
Infectious disease (2814)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (120)
Interviews (322)
IPO (16610)
IRA (44)
Job creations (3656)
Job search strategy (1453)
Kidney cancer (13)
Labor market (52)
Layoffs (500)
Leadership (18)
Legal (7967)
Liver cancer (79)
Longevity (11)
Lung cancer (405)
Lymphoma (210)
Machine learning (11)
Management (58)
Manufacturing (393)
MASH (92)
Medical device (13524)
Medtech (13529)
Mergers & acquisitions (19642)
Metabolic disorders (854)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (118)
Neuropsychiatric disorders (32)
Neuroscience (2138)
NextGen: Class of 2025 (6553)
Non-profit (4522)
Now hiring (47)
Obesity (431)
Opinion (224)
Ovarian cancer (101)
Pain (107)
Pancreatic cancer (121)
Parkinson's disease (187)
Partnered (22)
Patents (302)
Patient recruitment (168)
Peanut (50)
People (57853)
Pharmaceutical (64)
Pharmacy benefit managers (22)
Phase I (20892)
Phase II (29524)
Phase III (21986)
Pipeline (1642)
Policy (202)
Postmarket research (2573)
Preclinical (8928)
Press Release (65)
Prostate cancer (140)
Psychedelics (37)
Radiopharmaceuticals (254)
Rare diseases (463)
Real estate (5947)
Recruiting (67)
Regulatory (22761)
Reports (50)
Research institute (2351)
Resumes & cover letters (358)
Rett syndrome (9)
RNA editing (8)
RSV (50)
Schizophrenia (86)
Series A (157)
Series B (109)
Service/supplier (11)
Sickle cell disease (60)
Special edition (20)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3607)
State (2)
Stomach cancer (14)
Supply chain (77)
Tariffs (58)
The Weekly (40)
Vaccines (782)
Venture capital (54)
Weight loss (258)
Women's health (47)
Worklife (16)
Date
Today (91)
Last 7 days (376)
Last 30 days (1854)
Last 365 days (31259)
2025 (16891)
2024 (35292)
2023 (40142)
2022 (51269)
2021 (55839)
2020 (54233)
2019 (46721)
2018 (35186)
2017 (32288)
2016 (31725)
2015 (37789)
2014 (31550)
2013 (26644)
2012 (28872)
2011 (29546)
2010 (27562)
Location
Africa (730)
Alabama (61)
Alaska (7)
Arizona (244)
Arkansas (13)
Asia (38486)
Australia (6283)
California (7462)
Canada (2364)
China (676)
Colorado (320)
Connecticut (319)
Delaware (192)
Europe (82901)
Florida (1122)
Georgia (249)
Hawaii (1)
Idaho (59)
Illinois (639)
India (27)
Indiana (361)
Iowa (17)
Japan (229)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1028)
Massachusetts (5547)
Michigan (246)
Minnesota (452)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (66)
New Jersey (2083)
New Mexico (28)
New York (2091)
North Carolina (1083)
North Dakota (8)
Northern California (3285)
Ohio (237)
Oklahoma (16)
Oregon (34)
Pennsylvania (1615)
Puerto Rico (17)
Rhode Island (36)
South America (1110)
South Carolina (34)
South Dakota (1)
Southern California (2792)
Tennessee (126)
Texas (1127)
United States (27652)
Utah (221)
Virginia (187)
Washington D.C. (72)
Washington State (634)
West Virginia (4)
Wisconsin (66)
708,825 Results for "berkeley lights inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for Rehearing
AbCellera (Nasdaq: ABCL) announced that the United States Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTAB) has denied a rehearing request in an Inter Partes Review (IPR) filed by Berkeley Lights, Inc. (Berkeley Lights) that challenged AbCellera’s U.S. Patent No. 10,087,408 (the ‘408 Patent).
July 24, 2023
·
4 min read
Business
Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results
Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today reported financial results for the fourth quarter and full year ended December 31, 2022.
February 23, 2023
·
11 min read
Deals
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
Berkeley Lights and IsoPlexis announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million.
December 21, 2022
·
14 min read
Business
Berkeley Lights Reports Third Quarter 2022 Financial Results
Berkeley Lights, Inc., a leader in digital cell biology, reported financial results for the quarter ended September 30, 2022.
November 8, 2022
·
7 min read
Deals
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome.
March 21, 2023
·
6 min read
Biotech Bay
Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development
Berkeley Lights, Inc., a life sciences tools company, announced the launch of the Beacon Select™, the company’s new optofluidic system for cell line development.
January 9, 2023
·
4 min read
Biotech Bay
Berkeley Lights to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Berkeley Lights, Inc., a life sciences tools company, announced the Company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.
January 3, 2023
·
2 min read
Business
Berkeley Lights to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
Berkeley Lights, Inc., a life sciences tools company, announced that the Company will be reporting financial results for the fourth quarter and full year 2022 after market on Thursday, February 23, 2023.
February 13, 2023
·
2 min read
Business
Berkeley Lights Reports Second Quarter 2022 Financial Results
Berkeley Lights, Inc., a leader in digital cell biology, reported financial results for the quarter ended June 30, 2022.
August 9, 2022
·
7 min read
Press Releases
Stars Shine a Light on Type 1 Diabetes at The Breakthrough T1D 2025 Children’s Congress
June 27, 2025
·
4 min read
1 of 70,883
Next
